Amgen (AMGN) stock falls as Cantor Fitzgerald raises safety concerns over bone mineral density loss linked to obesity ...

Analysts cited data from a phase one study showing the highest dose of Amgen’s MariTide was linked to roughly 4% loss of bone ...

On Tuesday, a tiny shred of data on Amgen’s lead obesity candidate — not yet verified — erased $12 billion in market value.

Other products are Repatha, Blincyto, Vectibix, Nplate, Kyprolis ... rating. Shares of Amgen are trading at a forward earnings multiple of 16.4X, as well as a PEG Ratio of 2.8, a Price/Cash Flow ratio ...

Amgen (NASDAQ:AMGN – Free Report) had its target price cut by UBS Group from $335.00 to $326.00 in a report released on Thursday, Benzinga reports. They currently have a neutral rating on the medical ...

With increasing chronic diseases, demand for personalized medicines, and adoption of AI, the biotech market is booming.

THOUSAND OAKS, Calif., Oct. 30, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced financial results for the third quarter of 2024.

UBS lowered the firm’s price target on Amgen (AMGN) to $326 from $335. Amgen reported in-line topline sales for Q3, with most products as ...

AMGN beats third-quarter estimates for earnings and matches the same for sales. It slightly raises 2024 sales guidance but narrows the EPS range.

The inflation rate in Germany is expected to be 2.0% in October 2024. It is measured as the change in the consumer price index (CPI) compared with the same month a year earlier. Based on the results ...

Thanks to clearance sales from retailers like Amazon, we expect these high-end screens to receive impressive price cuts in the next few weeks. That's why we're keeping you updated with a weekly ...

Amgen (NASDAQ:AMGN – Get Free Report) will be releasing its earnings data before the market opens on Wednesday, October 30th.